Abstract
The complexity and the uncertainties about long-term effect of the invasive interventions to treat essential hypertension (HTN) require a precise diagnosis about the real “resistance” to the antihypertensive treatment given, and it is defined when a therapeutic strategy that includes appropriate lifestyle measures plus a diuretic and two other antihypertensive drugs belonging to different classes at adequate doses fails to lower systolic blood pressure (SBP) and diastolic blood pressure (DBP) values to <140 and 90 mmHg, respectively. Consequently, in the process of diagnosis and follow-up, blood pressure (BP) measurement is the first step that is not exempt of difficulties due to the variability of BP as a parameter. It has long been known that BP is characterized by an array of spontaneous variations. BP values vary markedly within the 24 h because of day-night changes but also because of differences among hours, minutes, and even adjacent beats. They also show variations over more prolonged periods because of differences among days, months, and season [1]. Even though it has been discussed, the prognostic relevance of the different kinds of variability in the case of resistant hypertension is a challenge at the time of evaluation. Several factors have been associated to the high day-to-day variability of patients with resistant hypertension and among them the number of drugs prescribed [2]. Therefore, more precise BP is mandatory in order to take the right decisions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- ABPM:
-
Ambulatory blood pressure monitoring
- BP:
-
Blood pressure
- DBP:
-
Diastolic blood pressure
- HTN:
-
Hypertension
- PWV:
-
Pulse wave velocity
- RDN:
-
Renal denervation
- SBP:
-
Systolic blood pressure
References
Mancia G (2012) Short- and Long-term blood pressure variability. Hypertension 60:512–517
Howard JP, Patel H, Shun-Shin MJ, Mourad JJ, Blacher J, Mahfoud F et al (2015) Impact of number of prescribed medications on visit-to-visit variability of blood pressure: implications for design of future trials of renal denervation. J Hypertens 33:2359–2367
Herbert A, Cruickshank JK, Laurent S, Boutouyrie P, Reference Values for Arterial Measurements Collaboration (2014) Establishing reference values for central blood pressure and its amplification in a general healthy population and according to cardiovascular risk factors. Eur Heart J 35:3122–3133
Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, Task Force Members et al (2013) 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 31:1281–1357
Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y, ESH Working Group on Blood Pressure Monitoring et al (2010) European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens 24:779–785
Pascual JM, Rodilla E, Costa JA, Garcia-Escrich M, Gonzalez C, Redon J (2014) Prognostic value of microalbuminuria during antihypertensive treatment in essential hypertension. Hypertension 64:1228–1234
Muxfeldt ES, Fiszman R, de Souza F, Viegas B, Oliveira FC, Salles GF (2012) Appropriate time interval to repeat ambulatory blood pressure monitoring in patients with white-coat resistant hypertension. Hypertension 59:384–389
Persu A, Jin Y, Azizi M, Baelen M, Völz S, Elvan A, European Network COordinating research on Renal Denervation (ENCOReD) et al (2014) Blood pressure changes after renal denervation at 10 European expert centers. J Hum Hypertens 28:150–156
Rohla M, Nahler A, Lambert T, Reiter C, Gammer V, Grund M et al (2016) Predictors of response to renal denervation for resistant arterial hypertension: a single center experience. J Hypertens 34:123–129
Doumas M, Anyfanti P, Bakris G (2012) Should ambulatory blood pressure monitoring be mandatory for future studies in resistant hypertension: a perspective. J Hypertens 30:874–876
Mahfoud F, Ukena C, Schmieder RE, Cremers B, Rump LC, Vonend O et al (2013) Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension. Circulation 128:132–140
Lambert T, Blessberger H, Gammer V, Nahler A, Grund M, Kerschner K et al (2014) Effects of renal denervation on ambulatory blood pressure measurements in patients with resistant arterial hypertension. Clin Cardiol 37:307–311
Ott C, Mahfoud F, Schmid A, Ditting T, Sobotka PA, Veelken R, Spies A, Ukena C, Laufs U, Uder M, Böhm M, Schmieder RE (2013) Renal denervation in moderate treatment-resistant hypertension. J Am Coll Cardiol 62:1880–1886
Bakris GL, Townsend RR, Liu M, Cohen SA, D’Agostino R, Flack JM, SYMPLICITY HTN-3 Investigators et al (2014) Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3. J Am Coll Cardiol 64:1071–1078
Mancia G, Parati G (2004) Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: a meta-analysis. J Hypertens 22:435–445
Brandt MC, Reda S, Mahfoud F, Lenski M, Böhm M, Hoppe UC (2012) Effects of renal sympathetic denervation on arterial stiffness and central hemodynamics in patients with resistant hypertension. J Am Coll Cardiol 60:1956–1965
Mortensen K, Franzen K, Himmel F, Bode F, Schunkert H, Weil J, Reppel M (2012) Catheter-based renal sympathetic denervation improves central hemodynamics and arterial stiffness: a pilot study. J Clin Hypertens 14:861–870
Ott C, Janka R, Schmid A, Titze S, Ditting T, Sobotka PA et al (2013) Vascular and renal hemodynamic changes after renal denervation. Clin J Am Soc Nephrol 8:1195–1201
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Redon, J. (2016). Blood Pressure Measurement Before and After Intervention. In: Tsioufis, C., Schmieder, R., Mancia, G. (eds) Interventional Therapies for Secondary and Essential Hypertension. Updates in Hypertension and Cardiovascular Protection. Springer, Cham. https://doi.org/10.1007/978-3-319-34141-5_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-34141-5_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-34140-8
Online ISBN: 978-3-319-34141-5
eBook Packages: MedicineMedicine (R0)